Volume 73, Issue 6 , Pages 314-318, June 2010
Newborn Screening for Methylmalonic Aciduria by Tandem Mass Spectrometry: 7 Years' Experience From Two Centers in Taiwan
Article Outline
Background
The clinical course of methylmalonic aciduria (MMA) is fulminant in neonates and emergency management is necessary to save lives. It is therefore very important to differentiate affected from unaffected neonates immediately when there are abnormal results regarding MMA in newborn screening.
Methods
Between January 2002 and December 2008, 598,522 newborns were screened for MMA by 2 neonatal screening centers: the Chinese Foundation of Health and the Taipei Institute of Pathology. A total of 22 newborns were referred to confirmatory medical centers, and 7 were confirmed as having MMA. The initial propionylcarnitine (C3) level, C3/acetylcarnitine (C2) ratio, plasma ammonia, liver function tests, blood pH and bicarbonate were compared between the true-positive and false-positive groups.
Results
The C3/C2 ratio and plasma ammonia were markedly higher in the true-positive MMA group (p < 0.0001). Blood gas pH (p = 0.029), bicarbonate (p = 0.019), and aspartate aminotransferase (p = 0.005) also significantly differed between these 2 groups.
Conclusion
Referred newborns with elevated plasma C3/C2 ratios > 0.4 or ammonia levels > 200 mg/dL should be highly suspected of having MMA.
Key Words: methylmalonic aciduria , newborn screening , Taiwan , tandem mass spectrometry
No full text is available. To read the body of this article, please view the PDF online.
References
- Diagnostic work-up and management of patients with isolated methylmalonic acidurias in European metabolic centres . J Inherit Metab Dis . 2008;31:361–367
- . Molecular basis of methylmalonyl-CoA mutase apoenzyme defect in 40 European patients affected by mut0 and mut− forms of methylmalonic acidemia: identification of 29 novel mutations in the MUT gene . Hum Mutat . 2005;25:167–176
- . Inherited metabolic disorders and cerebral infarction . Expert Rev Neurother . 2008;8:1731–1741
- . Methylmalonic acidemia (MMA) . Mol Genet Metab . 2005;85:2–6
- Long-term outcome in methylmalonic aciduria: a series of 30 French patients . Mol Genet Metab . 2009;97:172–178
- Brain damage by mild metabolic derangements in methylmalonic acidemia . Pediatr Neurol . 2008;39:325–329
- Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan . J Chromatogr B . 2002;776:39–48
- . Expanded neonatal screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications . Pediatrics . 2003;111:1399–1406
- . Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns . Clin Chem . 2003;49:1797–1817
- . Screening newborns for inborn errors of metabolism by tandem mass spectrometry . N Engl J Med . 2003;348:2304–2312
- . Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry . Clin Chem . 2007;53:1364–1369
- . Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria: a possible explanation for hyperammonemia in propionic and methylmalonic aciduria . J Clin Invest . 1979;64:1544–1551
PII: S1726-4901(10)70067-8
doi:10.1016/S1726-4901(10)70067-8
© 2010 Elsevier. Published by Elsevier Inc. All rights reserved.
Volume 73, Issue 6 , Pages 314-318, June 2010
